During the past decade, Gottsegen György Országos Kardiológiai Intézet conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 17 clinical trials were completed, i.e. on average, 81% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 11 clinical trials were completed. i.e. 122.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gottsegen György Országos Kardiológiai Intézet" #1 sponsor was "Actelion" with 10 trials, followed by "Aires Pharmaceuticals, Inc." with 2 trials sponsored, "Amgen" with 2 trials sponsored, "Bayer" with 2 trials sponsored and "Idorsia Pharmaceuticals Ltd." with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gottsegen György Országos Kardiológiai Intézet" #1 collaborator was "ABX CRO" with 1 trials as a collaborator, "AG Mednet Inc." with 1 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator and "Advanced Clinical, LLC" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Gottsegen György Országos Kardiológiai Intézet" are "Pulmonary Arterial Hypertension" (8 trials), "Heart Failure" (4 trials), "Atrial Fibrillation" (3 trials), "Coronary Artery Disease" (3 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Gottsegen György Országos Kardiológiai Intézet" in a lesser frequency.

Most popular intervention types in "Gottsegen György Országos Kardiológiai Intézet" are "Drug" (24 trials), "Other" (4 trials), "Procedure" (4 trials), "Device" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Macitentan" (3 trials), "Selexipag" (3 trials), "Edoxaban" (2 trials) and "Macitentan 10 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Gottsegen György Országos Kardiológiai Intézet" are 33 trials for "All" genders.

Currently, there are NaN active trials in "Gottsegen György Országos Kardiológiai Intézet". undefined are not yet recruiting, 8 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 13 completed trials in Gottsegen György Országos Kardiológiai Intézet, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Gottsegen György Országos Kardiológiai Intézet, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".

Gottsegen György Országos Kardiológiai Intézet has several departments that took part in Clinical trials: "Hungarian Paediatric Heart Centre, Göttsegen Gyorgy Hungarian Institute of Cardiology" - 9 trials